UBS's Market Stabilization in AvePoint's SGX Listing: A Strategic Boost for Investor Confidence

In September 2025, AvePoint made history as the first B2B SaaS company to achieve a dual listing on both the Nasdaq and Singapore Exchange (SGX). This landmark event, marked by a secondary offering of 13.29 million shares, underscored the growing appeal of SGX as a hub for high-growth technology firms. Central to this success was UBS AG, Singapore Branch, which played a pivotal role in stabilizing the offering through targeted market interventions. According to the Stabilization Announcement, UBS executed a stabilization strategy by purchasing 35,300 shares at S$19.50, directly supporting the share price and signaling confidence in the listing's viability.

Stabilization Strategies: A Cornerstone of Market Confidence

UBS, alongside Jefferies, Morgan Stanley, and Oversea-Chinese Banking Corporation, acted as a joint global coordinator and bookrunner for the offering, according to Yahoo Finance. The firm's stabilization measures were critical in mitigating volatility during the listing's early stages. By purchasing shares at the offering price, UBS demonstrated a commitment to maintaining liquidity and price stability-a tactic often employed in secondary offerings to reassure investors. This approach aligns with broader market practices, where underwriters use stabilization funds to absorb short-term supply shocks and prevent panic-driven sell-offs.

The offering, valued at approximately S$259 million, included an additional option for underwriters to purchase 1.99 million shares, further enhancing flexibility in managing demand, as reported by Yahoo Finance. Such strategies are particularly vital in cross-border listings, where investor familiarity with the issuer may be limited. UBS's actions not only stabilized AvePoint's shares but also reinforced SGX's reputation as a reliable platform for global capital raising.

Investor Confidence: Oversubscription and Strategic Alliances

The secondary offering was more than three times oversubscribed, reflecting robust demand from institutional and long-only investors, according to Investing.com. This level of interest highlights the strategic value of SGX as a secondary listing venue, particularly for firms seeking to diversify their investor base. AvePoint's dual listing allowed it to tap into both U.S. and Asian markets, a move lauded by SGX Securities as a testament to its role in fostering international capital flows.

UBS's involvement in the offering was further bolstered by its strong Q3 2025 performance, which saw net profits nearly double consensus estimates and a 7% revenue increase, as reported by Investing.com. The firm's announcement of 2025 buybacks signaled a commitment to shareholder returns, indirectly reinforcing investor confidence in its underwriting capabilities. As noted by Investing.com, UBS's financial resilience and strategic focus likely contributed to a broader sense of optimism in the market, benefiting firms like AvePoint during critical capital-raising periods.

Implications for Future Listings

AvePoint's successful SGX listing, supported by UBS's stabilization strategies, sets a precedent for other technology firms seeking dual-listing opportunities. The offering's oversubscription and SGX's endorsement underscore the exchange's growing influence in attracting high-growth companies. For underwriters like UBS, the experience reinforces the importance of tailored stabilization measures in navigating complex cross-border markets.

Conclusion

UBS's market intervention during AvePoint's SGX listing exemplifies the strategic interplay between stabilization strategies and investor confidence. By leveraging its underwriting expertise and financial strength, UBS not only ensured a smooth listing but also highlighted SGX's potential as a global capital-raising hub. As technology firms increasingly pursue dual-listing strategies, the lessons from this offering will remain relevant for both issuers and underwriters navigating dynamic market conditions.